ABVEW Above Food Ingredients Inc. - Fundamental Analysis

BEARISH

ABVEW Stock | Fundamental Analysis & Investment Insights

NASDAQ • N/A • N/A

Current Price Live

$0.37

52W High

$0.46

52W Low

$0.37

Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Feb 21, 2026

Market cap

N/A

P/E

N/A

ROE

N/A

Profit margin

-23.4%

Debt/Equity

N/A

Dividend yield

N/A

AI Analysis

Confidence Score

92%

Analysis Accuracy

ABVEW exhibits severe financial distress, as indicated by a Piotroski F-Score of 4/9 (borderline stable but weak), a critically low current ratio of 0.23 and quick ratio of 0.07, and a negative Price/Book of -0.85, signaling deep insolvency risk. The company reports a -23.36% profit margin, -45% YoY revenue decline, and no meaningful profitability or cash flow data, reinforcing deteriorating fundamentals. With no analyst coverage, no dividend, and a technical trend score of 0/100, the stock lacks any positive momentum or institutional validation. The Graham Number and intrinsic value are unavailable, and the current price of $0.37 is near its 52-week low, offering no margin of safety. Overall, the company is in a state of financial deterioration with high distress risk.

Key Strengths

Trading near 52-week low may present a speculative entry point for contrarian investors

Low market cap could allow for high volatility-based upside if turnaround occurs

Insider sentiment at 40/100 suggests minimal negative activity (no large sell-offs)

Price is below 52-week high, indicating potential short-term oversold conditions

No reported debt or equity data may imply minimal leverage, though this is likely due to insolvency

Key Risks

Piotroski F-Score of 4 indicates weak financial health and declining operational efficiency

Current ratio of 0.23 and quick ratio of 0.07 signal extreme liquidity risk and potential insolvency

Negative gross margin (-2.76%) and operating margin (-23.25%) reflect fundamental business model failure

Revenue has declined 45% YoY, with no signs of recovery or growth

No analyst coverage or target price implies lack of market interest and high uncertainty

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

High Risk

Key drivers: Piotroski F-Score of 4/9, Negative profitability and revenue decline, Extremely weak liquidity ratios, No analyst coverage or valuation metrics, Technical trend at 0/100

Confidence

90%

Value

15/100

Ref P/E, PEG, Graham Number

Positives

Trading near 52-week low ($0.37)

Watchpoints

No Graham Number or intrinsic value available
Price/Book of -0.85 indicates negative equity
No P/E, PEG, or Price/Sales data to support valuation
No cash flow or earnings to support any valuation model

Future

10/100

Ref Growth rates

Positives

No new debt reported (possible lack of leverage)

Watchpoints

Revenue down 45% YoY with no growth indicators
No forward P/E or earnings growth data
No operating cash flow or free cash flow reported
No analyst estimates or guidance

Past

20/100

Ref Historical trends

Positives

Price has remained stable at $0.37 for extended period

Watchpoints

52-week high is $0.46, indicating downward trend
No historical growth or profitability data
No dividend history or payout record
No consistent financial reporting visible

Health

12/100

Ref Altman Z-Score, Piotroski F-Score

Positives

No reported debt/Equity ratio (possibly no debt)

Watchpoints

Piotroski F-Score of 4/9 (weak)
Current ratio of 0.23 (extremely low)
Quick ratio of 0.07 (near zero liquidity)
Negative Price/Book (-0.85) implies negative equity
No Altman Z-Score available, but ratios suggest distress

Dividend

0/100

Ref Yield, Payout

Positives

No standout positives identified.

Watchpoints

Dividend Strength: 0/100
No dividend yield, rate, or payout ratio
No history of dividend payments
Company is unprofitable and likely cannot afford dividends

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$0.37

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ABVEW and closest competitors.

Updated 2026-02-20

Company	5Y	3Y	1Y	6M	1M	1W
ABVEW Above Food Ingredients Inc. Primary	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

N/A

-0.85

N/A

Profitability

Profit margins and return metrics

Profit Margin -23.36%

Operating Margin -23.25%

Gross Margin -2.76%

ROE N/A

ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth -45.0%

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

N/A

Current Ratio

0.23

Weak

Quick Ratio

0.07

Poor

Cash/Share

$0.02

Past News Coverage

Recent headlines mentioning ABVEW from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V1 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends